Vanguard Group Inc Rocket Pharmaceuticals, Inc. Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 5,536,940 shares of RCKT stock, worth $63.3 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,536,940
Previous 5,808,550
4.68%
Holding current value
$63.3 Million
Previous $125 Million
18.22%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding RCKT
# of Institutions
209Shares Held
93.2MCall Options Held
319KPut Options Held
70.3K-
Rtw Investments, LP New York, NY17.7MShares$202 Million5.21% of portfolio
-
Wellington Management Group LLP Boston, MA11.2MShares$128 Million0.04% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$70.8 Million0.0% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.49MShares$51.4 Million0.39% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx4.12MShares$47.1 Million1.58% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $865M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...